Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock By Investing.com
SAN DIEGO—Allan Camaisa, CEO and Chairman of the Board at Calidi Biotherapeutics, Inc. (NASDAQ:CLDI), recently sold 10,000 shares of the company’s common stock. The shares were sold at a price of $1.62 each, amounting to a total transaction value of $16,200. Following this sale, Camaisa holds 66,712 shares directly. The transaction comes as CLDI shares … Read more